来自龙头林德伯基的素丰富分离物:高血压治疗的有希望的药物
Zahra Pezeshki1, Muhammad Hussein Vakily2, Mahnaz Vaez2
1Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran.
International journal of preventive medicine
|June 16, 2025
概括
来自Dracocephalum lindbergii的黄类分离物显示出显著的降血压效应. 富含丁醇的分数,特别是6分数,表现出强大的血管扩张特性,表明它们对高血压管理的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 植物化学 植物化学
- 心血管研究研究心血管研究
背景情况:
- 高血压 (高血压) 是一个严重的健康问题,需要有效的预防和管理策略.
- 传统医学经常利用药用植物的组合,如Dracocephalum lindbergii,用于管理高血压.
- 这项研究调查了来自D. lindbergii的黄类分离物的血管扩张作用.
研究的目的:
- 评估来自D. lindbergii. 的富含黄化合物的血动力学特性.
- 探索D. lindbergii提取物的潜力,作为预防和控制高血压的新方法.
- 为了确定负责观察到的降血压效应的特定化合物.
主要方法:
- 使用染色学准备了黄素分数.
- 血液动力学参数 (静脉缩,腹缩,平均动脉压) 被监测在烯诱导的高血压的老鼠模型中.
- 使用聚胺和塞法德克斯列分析生物活性分数,并通过NMR光谱学识别化合物.
主要成果:
- 富含黄素的部分 (3, 4, 5, 6) 在高血压大鼠中显著降低了静缩和静缩血压.
- 分数6和分数4表现出最明显的降血压效应.
- 发现的关键化合物包括apigenin衍生物 (分数4) 和luteolin衍生物 (分数6).
结论:
- 林德伯格菌的黄素分数,特别是富含黄素的6分数,显示出有前途的抗高血压作用.
- 这些发现支持D. lindbergii的传统使用,并表明其作为血压控制的补充干预措施的潜力.
- 来自D. lindbergii的氨酸衍生物因其在治疗基本高血压方面的功效而受到重视.
更多相关视频
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
19.3K
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.2K
相关概念视频
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
56
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
56
01:26Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
796
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
796
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
642
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
642
01:17Antihypertensive Drugs: Action of β1 Blockers
635
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
635
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
913
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
913